Non-invasive imaging technologies:
The term noninvasive is used to denote a procedure where no instrument is introduced into a patient's body which is the case for most imaging techniques used. Medical imaging has become a major tool in clinical trials since it enables rapid diagnosis with visualization and quantitative assessment. Imaging is able to reveal subtle change that is indicative of the progression of therapy that may be missed out by more subjective, traditional approaches. Statistical bias is reduced as the findings are evaluated without any direct patient contact. Imaging biomarkers (a characteristic that is objectively measured by an imaging technique, which is used as an indicator of pharmacological response to a therapy) and surrogate endpoints have shown to facilitate the use of small group sizes, obtaining quick results with good statistical power.
Subtracks:
1. Magneto encephalography (MEG)
2. Magnetic Resonance Imaging (MRI)
3. Functional MRI (fMRI)
4. Magnetic Resonance Spectroscopy (MRS)
5. Positron Emission Tomography (PET)
6. Event-Related Optical Signals (EROS)
7. Transcranial Magnetic Stimulation (TMS)
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
